[144] Guidewire Software, Inc. SEC Filing
Rhea-AI Filing Summary
Guidewire Software, Inc. (GWRE) notice reports a proposed sale under Rule 144 of 1,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $249,860, intended for sale on 09/18/2025 on the NYSE. The filing shows the shares were originally acquired as restricted stock and performance shares on 09/15/2023 (194 restricted, 806 performance). The filer also disclosed a separate sale of 1,811 shares on 09/16/2025 generating $439,832.92.
Positive
- Transparent disclosure of proposed sale amount (1,000 shares) and aggregate market value ($249,860)
- Broker identified as Morgan Stanley Smith Barney facilitating the proposed transaction
- Acquisition details provided: restricted stock and performance shares dated 09/15/2023
- Recent sale disclosed (1,811 shares on 09/16/2025) with gross proceeds ($439,832.92)
Negative
- No issuer address or SEC file number provided in the visible issuer section of the filing
- No trading-plan adoption date disclosed, limiting clarity on Rule 10b5-1 reliance
Insights
TL;DR: Routine insider sale notice disclosing small-scale disposals with no new financial data.
The Form 144 documents proposed and recent insider sales rather than operational results. The proposed sale of 1,000 shares valued at $249,860 and a prior sale of 1,811 shares for $439,832.92 are disclosed through an institutional broker. There are acquisition dates shown (09/15/2023) indicating award origin as restricted and performance-based equity. This filing is procedural compliance under Rule 144 and does not provide revenue, earnings, or material corporate developments.
TL;DR: Compliance-focused disclosure; items reflect executive equity vesting and subsequent sales.
The document records insider disposals and the nature of original awards (restricted stock and performance shares), fulfilling disclosure and attestation requirements. The filer affirms lack of undisclosed material adverse information. No governance actions, director changes, or trading-plan dates are specified on the form, limiting assessment to standard disclosure of planned sales.